New therapeutic paradigms
Autor(a) principal: | |
---|---|
Data de Publicação: | 2000 |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://revista.spmi.pt/index.php/rpmi/article/view/2001 |
Resumo: | Today's drug therapy offers examples, models and norms which are analysed in this short overview. The main conclusion to be drawn is that albeit new and important drugs are being introduced, there is no need to establish new principies governing therapy. Drug research has experienced in the Jast decade new and important developments, as exemplified by its interdisciplinary scope, use of new technologies (genetics, genomics, computer science, combinatory chemistry, etc.), search for more selective and specific drugs, early intervention oi clinicians in the experimental planning, growing attention given to orphan diseases and those predominating in poor developping countries. Even the notion oi remedy or drug has changed, now being extended to chemical entities which alter physiological mechanisms (for exemple, contraceptives, sildenafil, arcabose, orlistat, etc.) None of these alterations, novelties and evolutions justifies an adoption of new therapeutic norms, the classical principles of doing no harm, benefiting the patient and giving priority to his or her good continuing to be of paramount importance. Used in this way, drugs will continue to be what Galen called them, "deorum quasi manus sunt". |
id |
RCAP_9995bed1aeef5b258a9a8fe20d23ebc4 |
---|---|
oai_identifier_str |
oai:oai.revista.spmi.pt:article/2001 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
New therapeutic paradigmsNovos paradigmas da terapêuticaterapêutica medicamentosainvestigação de medicamentosnovos modelosdrug therapydrug researchnew modelsToday's drug therapy offers examples, models and norms which are analysed in this short overview. The main conclusion to be drawn is that albeit new and important drugs are being introduced, there is no need to establish new principies governing therapy. Drug research has experienced in the Jast decade new and important developments, as exemplified by its interdisciplinary scope, use of new technologies (genetics, genomics, computer science, combinatory chemistry, etc.), search for more selective and specific drugs, early intervention oi clinicians in the experimental planning, growing attention given to orphan diseases and those predominating in poor developping countries. Even the notion oi remedy or drug has changed, now being extended to chemical entities which alter physiological mechanisms (for exemple, contraceptives, sildenafil, arcabose, orlistat, etc.) None of these alterations, novelties and evolutions justifies an adoption of new therapeutic norms, the classical principles of doing no harm, benefiting the patient and giving priority to his or her good continuing to be of paramount importance. Used in this way, drugs will continue to be what Galen called them, "deorum quasi manus sunt".Analisam-se os exemplos, modelos e normativos que enquadram a terapêutica (medicamentosa), tal como hoje é praticada, para se concluir que em face de novos e importantes exemplos e modelos não se torna necessário instituir novas linhas orientadoras da terapêutica. São mencionadas as características da investigação de novos medicamentos, tais como hoje se verificam: interdisciplinidade, recurso a novas tecnologias (da genética, da genómica, da ciência dos computadores, da química combinatória, etc.), procura de medicamentos mais selectivos e mais específicos, intervenção precoce de clínicos no delineamento experimental, atenção crescente ás doenças órfãs e de predomínio nos países economi camente débeis. Regista-se a mudança observada no próprio conceito de medicamento, que agora inclui fármacos modificadores de funções normais (anticoncepcionais, sildenafil, acarbose, orlistat, etc.) Nenhuma destas modificações e evoluções leva a adoptar novos normativos na terapia, que continua a obedecer aos princípios clássicos do beneficio do doente, de não o prejudicar e de ter sempre presente o seu bem. Usados desta maneira, os medicamentos continuam a ser, como os definia Galeno, "deorum quasi manus sunt".Sociedade Portuguesa de Medicina Interna2000-09-29info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://revista.spmi.pt/index.php/rpmi/article/view/2001Internal Medicine; Vol. 7 No. 3 (2000): Julho/ Setembro; 178-180Medicina Interna; Vol. 7 N.º 3 (2000): Julho/ Setembro; 178-1802183-99800872-671Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revista.spmi.pt/index.php/rpmi/article/view/2001https://revista.spmi.pt/index.php/rpmi/article/view/2001/1401Osswald, W.info:eu-repo/semantics/openAccess2023-06-10T06:11:08Zoai:oai.revista.spmi.pt:article/2001Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:00:07.831214Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
New therapeutic paradigms Novos paradigmas da terapêutica |
title |
New therapeutic paradigms |
spellingShingle |
New therapeutic paradigms Osswald, W. terapêutica medicamentosa investigação de medicamentos novos modelos drug therapy drug research new models |
title_short |
New therapeutic paradigms |
title_full |
New therapeutic paradigms |
title_fullStr |
New therapeutic paradigms |
title_full_unstemmed |
New therapeutic paradigms |
title_sort |
New therapeutic paradigms |
author |
Osswald, W. |
author_facet |
Osswald, W. |
author_role |
author |
dc.contributor.author.fl_str_mv |
Osswald, W. |
dc.subject.por.fl_str_mv |
terapêutica medicamentosa investigação de medicamentos novos modelos drug therapy drug research new models |
topic |
terapêutica medicamentosa investigação de medicamentos novos modelos drug therapy drug research new models |
description |
Today's drug therapy offers examples, models and norms which are analysed in this short overview. The main conclusion to be drawn is that albeit new and important drugs are being introduced, there is no need to establish new principies governing therapy. Drug research has experienced in the Jast decade new and important developments, as exemplified by its interdisciplinary scope, use of new technologies (genetics, genomics, computer science, combinatory chemistry, etc.), search for more selective and specific drugs, early intervention oi clinicians in the experimental planning, growing attention given to orphan diseases and those predominating in poor developping countries. Even the notion oi remedy or drug has changed, now being extended to chemical entities which alter physiological mechanisms (for exemple, contraceptives, sildenafil, arcabose, orlistat, etc.) None of these alterations, novelties and evolutions justifies an adoption of new therapeutic norms, the classical principles of doing no harm, benefiting the patient and giving priority to his or her good continuing to be of paramount importance. Used in this way, drugs will continue to be what Galen called them, "deorum quasi manus sunt". |
publishDate |
2000 |
dc.date.none.fl_str_mv |
2000-09-29 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://revista.spmi.pt/index.php/rpmi/article/view/2001 |
url |
https://revista.spmi.pt/index.php/rpmi/article/view/2001 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://revista.spmi.pt/index.php/rpmi/article/view/2001 https://revista.spmi.pt/index.php/rpmi/article/view/2001/1401 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Medicina Interna |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Medicina Interna |
dc.source.none.fl_str_mv |
Internal Medicine; Vol. 7 No. 3 (2000): Julho/ Setembro; 178-180 Medicina Interna; Vol. 7 N.º 3 (2000): Julho/ Setembro; 178-180 2183-9980 0872-671X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799131669748252672 |